Velcade: Cancer Therapy
VELCADE® is the first oncology drug marketed and promoted by Millennium. The rapid clinical development of VELCADE-with FDA approval granted little more than four and a half years after initiation of the first clinical trial-reflects our intense commitment to novel treatments for cancer patients. To discover and develop such treatments, we focus on understanding key molecular pathways that play crucial roles in underlying disease processes, and on identifying therapeutically significant differences that may exist between people.
Embed code for Blogs
Simply copy and paste the following HTML code below into your blog, website, or MySpace profile.
Copy to Clipboard
Share this video:
Simply click the button below and select your social bookmarking site.
Tag Cloud
Category: Health & Care
VELCADE® is the first oncology drug marketed and promoted by Millennium. The rapid clinical development of VELCADE-with FDA approval granted little more than four and a half years after initiation of the first clinical...
Tags:
myeloma, drugs, treatment, patients, mcl, mantle cell lymphoma, fda, velcade, therapy, cancer, health
Views: 11551
Lufthansa 80 years in China
First ever convertible crash test
UNICEF: Tsunami Two Year Update
Ford Models 360 - Spring Fashions
UNICEF: Communities in Afghanistan stand up to violence and send children to school
Stop Alcohol Abuse: David
Scenes from Live8: Madonna
A rural health care center plays key role in reducing infant and child mortality
UNICEF Helping children cope after violence in Gaza
Ducati Marlboro Team
UNICEF: Nafa centers give Guinean girls a second chance at education
UNICEF - Ivory coast psycho social problem
UNICEF: Children affected by HIV-AIDS meet parliamentarians at Mozambique conference
Small Step: Belly
Year-end Watchdog Report - Brand name drug prices continue to rise
UNICEF A call for aid to has undernourished children
Tree Canada Foundation: Neighborhood
Verizon Wireless Chaperone Educational Video Chapter 2
AARP: Chronic Fatigue Syndrome Facts